跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 75,346 条关于
“Gen-2 SYNC DIFS”
全部
75,346
临床试验
49,695
药物
9,193
机构
1,498
资讯
14,960
11个月前
Nexalin's Neurostimulation Device Shows Significant Cognitive Improvements in Alzheimer's Disease Trial
15天前
Nexalin's Item-Level ADAS-Cog Analysis Reveals Domain-Specific Cognitive Gains in Alzheimer's Trial
去年
Nexalin Technology Strengthens Scientific Advisory Board to Accelerate Alzheimer's Research with Novel Brain Stimulation Technology
去年
Nexalin Technology Appoints Carolyn Shelton as SVP of Clinical, Quality & Regulatory Affairs
10个月前
Syncromune's SYNC-T Therapy Shows Bone Metastases Resolution in Phase 1 Prostate Cancer Trial
4个月前
Syncromune's SYNC-T Therapy Shows 87% Response Rate in Metastatic Prostate Cancer Phase 1 Trial
9个月前
SYNC-T Therapy Shows 54% Complete Bone Metastasis Resolution in Phase 1 Prostate Cancer Trial
去年
FDA Approves Medtronic's Simplera Sync Sensor for MiniMed 780G System, Expanding CGM Options for Diabetes Management
去年
Syncromune to Present Phase 1 Data on Novel SYNC-T Therapy for Metastatic Prostate Cancer at ASCO 2025
去年
SYNC-T SV-102 Shows Promising Response in Metastatic Castration-Resistant Prostate Cancer
第 1 页,共 1496 页
上一页
下一页